Atrial Fibrillation Management and Outcomes
Atrial Fibrillation Management and Outcomes is a research topic within Cardiology and Cardiovascular Medicine. Science Explorer counts 73k research works in it since 1950. 15.7% of them reached the world's top 10% most cited for their field and year.
This cluster of papers focuses on the management, treatment, and risk assessment of atrial fibrillation (AF). It covers topics such as anticoagulant therapy, catheter ablation, stroke prevention, risk stratification, and guidelines for managing AF. The papers also compare different medications such as warfarin, rivaroxaban, and dabigatran for the treatment of AF.
- Atrial Fibrillation
- Anticoagulant Therapy
- Catheter Ablation
- Stroke Prevention
- Risk Stratification
- Guidelines
- Thromboembolism
- Warfarin
- Rivaroxaban
- Dabigatran
- Research works
- 73k fractional, since 1950
- In the world top 10%
- 11k per year above
- Top-10% rate
- 15.7% share of its works in the world top 10%
- Growth, 2013–17 → 2018–22
- +28% the tick is no change
This ranks research output and citation impact. It says nothing about the quality of diagnosis, treatment or care.
Which countries lead Atrial Fibrillation Management and Outcomes research?
By volume, the United States and China publish the most (3.9k and 1.7k works in 2022–2025).
By volume, 2022–2025
- 1 United States 3.9k works
- 2 China 1.7k works
- 3 Japan 1k works
- 4 Italy 777 works
- 5 Germany 755 works
- 6 United Kingdom 694 works
- 7 Spain 516 works
- 8 France 374 works
- 9 Canada 366 works
- 10 Australia 354 works
How concentrated that is
The same countries as shares of everything the list above accounts for. A node where two countries do two thirds of the work and one spread evenly across twelve read alike as a ranking and not at all alike here.
Shares of the rows listed above, not of the whole node.
Which institutions lead Atrial Fibrillation Management and Outcomes research?
By volume in 2022–2025, Chinese Academy of Medical Sciences & Peking Union Medical College publishes the most Atrial Fibrillation Management and Outcomes research, followed by Cleveland Clinic and University of Liverpool.
By volume, 2022–2025
- 1 Chinese Academy of Medical Sciences & Peking Union Medical College China 66 works
- 2 Cleveland Clinic United States 64 works
- 3 University of Liverpool United Kingdom 62 works
- 4 Capital Medical University China 59 works
- 5 Mayo Clinic in Arizona United States 52 works
- 6 Mayo Clinic United States 49 works
- 7 Harvard University United States 49 works
- 8 Brigham and Women's Hospital United States 48 works
- 9 Beijing Anzhen Hospital China 42 works
- 10 Liverpool Heart and Chest Hospital United Kingdom 41 works
Who are the leading researchers in Atrial Fibrillation Management and Outcomes?
The most-cited researchers publishing on Atrial Fibrillation Management and Outcomes include Graeme J. Hankey, Emelia J. Benjamin and Valentı́n Fuster.
- 1 Graeme J. Hankey 7.2k citations
- 2 Emelia J. Benjamin 6k citations
- 3 Valentı́n Fuster 5.4k citations
- 4 Winfried März 5.2k citations
Ranked by citations received across their whole record, among researchers with at least three works on this topic.
Where is Atrial Fibrillation Management and Outcomes research done?
The largest centres of Atrial Fibrillation Management and Outcomes research in 2022–2025 are Beijing (China), Tokyo (Japan), Seoul (South Korea) and New York (United States).
Largest cities, 2022–2025
Where is the best place to study Atrial Fibrillation Management and Outcomes?
Among universities, judged by research, University of Liverpool, Liverpool John Moores University and Aalborg University score highest, combining excellence, specialisation, size, growth and international reach. Research strength is one signal when choosing where to study; it does not measure teaching.
One dot per university in the table below. The upper left is the interesting corner: small places doing unusually strong work.
| # | University | Score | Top 10% | Specialisation | Works | Growth |
|---|---|---|---|---|---|---|
| 1 | University of Liverpool United Kingdom | 81.2 | 25.2% | 8.6× | 62 | +216.6% |
| 2 | Liverpool John Moores University United Kingdom | 71.4 | 39.5% | 8.5× | 19 | — |
| 3 | Aalborg University Denmark | 68.5 | 35.2% | 3.9× | 29 | +485.6% |
| 4 | Semmelweis University Hungary | 62.4 | 14.5% | 8.8× | 25 | +233.6% |
| 5 | University of Bern Switzerland | 58.0 | 35.6% | 3.5× | 21 | +68.4% |
| 6 | Chinese Academy of Medical Sciences & Peking Union Medical College China | 57.5 | 17.7% | 4.7× | 66 | +133.1% |
| 7 | Vrije Universiteit Brussel Belgium | 56.6 | 31.0% | 3.5× | 14 | +183.6% |
| 8 | Maastricht University Netherlands | 55.5 | 21.5% | 6.4× | 31 | +8.4% |
| 9 | University of Modena and Reggio Emilia Italy | 55.0 | 25.4% | 4.6× | 15 | +246.3% |
| 10 | University of Lübeck Germany | 54.1 | 21.6% | 6.6× | 14 | +141.4% |
Universities only. Score blends excellence (30%), specialisation (25%), size (20%), growth (15%) and international reach (10%), 2015–2022; growth compares 2010–14 with 2015–19.
Is Atrial Fibrillation Management and Outcomes research growing?
Output in 2018–2022 was 28% higher than in 2013–2017, peaking in 2025. The fastest-growing topics are Atrial Fibrillation Management and Outcomes.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Which topics inside it are moving
Growth and decline on one axis around a shared zero. Two lists side by side hide the thing that matters: whether the growth dwarfs the decline, or the other way round.